We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRC
576
DELISTED
First Republic Bank
FRC
| $1.9M | 0.01% |
10,145
-37,262
| -79% | -$6.85M |
|
577
Brookfield
BN
$103B
| $1.89M | 0.01% |
68,603
-7,727
| -10% | -$198K |
|
578
CoStar Group
CSGP
$11.9B
| $1.88M | 0.01% |
22,710
+3,520
| +18% | +$304K |
|
579
Enbridge
ENB
$121B
| $1.87M | 0.01% |
46,691
+9,197
| +25% | +$356K |
|
|
HES
580
DELISTED
Hess
HES
| $1.86M | 0.01% |
21,282
-3,427
| -14% | -$277K |
|
581
Devon Energy
DVN
$49.8B
| $1.86M | 0.01% |
63,572
+42,074
| +196% | +$1.09M |
|
582
McKesson
MCK
$99.5B
| $1.85M | 0.01% |
9,676
-25,599
| -73% | -$4.94M |
|
583
Keurig Dr Pepper
KDP
$41B
| $1.82M | 0.01% |
51,655
+17,006
| +49% | +$607K |
|
584
Crown Holdings
CCK
$12.9B
| $1.81M | 0.01% |
17,735
+17,717
| +98,428% | +$1.87M |
|
585
Principal Financial Group
PFG
$24B
| $1.8M | 0.01% |
28,483
+2,163
| +8% | +$138K |
|
586
Mesa Laboratories
MLAB
$540M
| $1.79M | 0.01% |
6,597
+26
| +0.4% | +$6.59K |
|
|
B
587
Barrick Mining
B
$62.6B
| $1.79M | 0.01% |
86,278
-8,560
| -9% | -$193K |
|
588
Alexandria Real Estate Equities
ARE
$8.96B
| $1.76M | 0.01% |
9,691
+678
| +8% | +$121K |
|
589
Take-Two Interactive
TTWO
$45.3B
| $1.74M | 0.01% |
9,852
-23,489
| -70% | -$4.17M |
|
590
UGI
UGI
$7.91B
| $1.74M | 0.01% |
37,599
-6,386
| -15% | -$287K |
|
591
Brown-Forman Class B
BF.B
$12.6B
| $1.73M | 0.01% |
23,032
+731
| +3% | +$55.7K |
|
|
PCH
592
DELISTED
PotlatchDeltic
PCH
| $1.72M | 0.01% |
+32,428
| New | +$1.87M |
|
593
Boston Properties
BXP
$11B
| $1.72M | 0.01% |
15,037
-453
| -3% | -$50.9K |
|
594
Darden Restaurants
DRI
$23.4B
| $1.71M | 0.01% |
11,703
+4,588
| +64% | +$646K |
|
595
Assurant
AIZ
$13.7B
| $1.7M | 0.01% |
10,892
-39,308
| -78% | -$6.14M |
|
596
The Mosaic Company
MOS
$7.1B
| $1.68M | 0.01% |
52,779
+37,995
| +257% | +$1.29M |
|
597
Skyworks Solutions
SWKS
$9.54B
| $1.68M | 0.01% |
8,781
-2,399
| -21% | -$426K |
|
598
Ulta Beauty
ULTA
$20.7B
| $1.65M | 0.01% |
4,769
-11,345
| -70% | -$3.72M |
|
599
International Paper
IP
$22.5B
| $1.64M | 0.01% |
28,240
-8,249
| -23% | -$471K |
|
|
TPIC
600
DELISTED
TPI Composites
TPIC
| $1.64M | 0.01% |
33,783
-6,660
| -16% | -$327K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.